Hederacoside C 3-methyl-5-methoxy-phenol 1-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside Niclosamide (BAY2353) is an orally

Niclosamide (BAY2353) is an orally bioavailable chlorinated salicylanilide

altered cellular oxygen consumption rate and induced production of pAMPK

RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation

Smiles: C[C@@H](O)[C@H](N)/C(/O)=N/[C@@H](CC1C=CC=CC=1)/C(/O)=N/[C@@H](CC(C)C)/C(/O)=N/[C@@H](CC(C)C)/C(/O)=N/[C@@H](CCCNC(N)=N)C(=N)O

Chemical Name: 2-aminopentanoic acid

Hederacoside C 3-methyl-5-methoxy-phenol 1-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside Niclosamide (BAY2353) is an orallyHederacoside C is a principal active ingredient of Hedera helix leaf that can treat respiratory disorders, because of its expectorant, bronchodilator, antibacterial, and bronchospasmolytic effects. Product information CAS Number: 14216 03 6 Molecular Weight: 1221. 38 Formula: C59H96O26 Chemical Name: 6 ({[3,4 dihydroxy 6 (hydroxymethyl) 5 [(3,4,5 trihydroxy 6 methyloxan 2 yl)oxy]oxan 2 yl]oxy}methyl) 3,4,5 trihydroxyoxan 2 yl 10 ({4,5 dihydroxy 3